Research & Development

99久久免费热在线精品久久re6热在线精品视频琪琪电影网直击|解读京东财报:营收增速反弹 刘强东“松口气”


  霍去病看了趙破奴一眼道︰“你身後是大漢的軍旗,不是馬賊的名號!”   “很應景啊,只是前面兩句跟後面兩句牛頭不對馬嘴,听起來很別扭!”99久久免费热在线精品   司馬遷睜開眼楮一字一句的道︰“據實而錄,留與後人評說!”久久re6热在线精品视频   游春馬就在城牆下,可能是因為那里的腐臭氣息太濃厚,它煩躁的倒騰著蹄子,不時地叫一聲。   在霍去病的身後,留下一道血肉模糊的道路。琪琪电影网   在霍去病的身後,留下一道血肉模糊的道路。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo